GM soybean oil leads to less obesity and insulin resistance but is still harmful to liver
According to a study, published inNature Scientific Reports, although a genetically-modified soybean oil was associated with lower risk of obesity and insulin resistance, it did not have beneficial effects on risk of diabetes or fatty liver disease.Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Genetics | Insulin | Liver | Liver Disease | Obesity | Science | Study | Urology & Nephrology